Search
for
Sort by
Research 421–450 of 1000+
- TGF-β Signaling: a Potential Therapeutic Target of Single Herbs and Extracts for Renal Fibrosis
- Hair growth induction by the tellurium immunomodulator AS101: association with delayed terminal differentiation of follicular keratinocytes and ras‐dependent up‐regulation of KGF expression
- Hair follicle regeneration suppresses Ras-driven oncogenic growth
- Studying the correlation of renin-angiotensin-system (RAS) components and insulin resistance in polycystic ovary syndrome (PCOs)
- Comparison of hair manifestations in cardio‐facio‐cutaneous and Costello syndromes highlights the influence of the RAS pathway on hair growth
- Injury suppresses Ras cell competitive advantage through enhanced wild-type cell proliferation
- QuantAnts machines discover biomarkers for RAS signaling activation and design sgRNAs for CRISPR to target complex CD9, CD34, and CD74.
- The malignant capacity of skin tumours induced by expression of a mutant H-ras transgene depends on the cell type targeted
- Co-operation between follicular ornithine decarboxylase and v-Ha-ras induces spontaneous papillomas and malignant conversion in transgenic skin
- Age-associated inflammation connects RAS-induced senescence to stem cell dysfunction and epidermal malignancy
- Inducible cre-mediated N-ras activation and PTEN inactivation in transgenic mouse melanocytes requires keratinocyte hyperplasia to elicit a melanocyte pathology
- Deregulated expression of E2F1 induces hyperplasia and cooperates with ras in skin tumor development
- Evidence that mirex promotes a unique population of epidermal cells that cannot be distinguished by their mutant Ha-ras genotype
- GLP-1 RAs and Skin Health: Exploring Dermatologic Side Effects and Therapeutic Interventions
- LB1011 Oncogenic ras mutation induces spatiotemporally specific tissue deformation through converting fluctuated into sustained ERK activation
- MicroRNA control of signal transduction
- Epidermal Notch signalling: differentiation, cancer and adhesion
- Cutaneous adverse effects of targeted therapies
- Inducible Cutaneous Inflammation Reveals a Protumorigenic Role for Keratinocyte CXCR2 in Skin Carcinogenesis
- RASopathic alopecia: Hair changes associated with vemurafenib therapy
- Commonalities Between COVID-19 and Radiation Injury
- The incidence and management of cutaneous adverse events of the epidermal growth factor receptor inhibitors
- DMBA/TPA Treatment Is Necessary for BCC Formation from Patched Deficient Epidermal Cells in Ptch flox/flox CD4Cre +/− Mice
- Antioxidants and Long Covid
- The Immun System Response İn Covıd-19 Infectıon İn Polycystıc Ovary Syndrome
- Understanding Cancer Cells of Origin in Cutaneous Tumors
- The Suppression of Very Long Chain Fatty Acids Is Associated with Skin Carcinogenesis
- Role of the bone morphogenetic protein signalling in skin carcinogenesis. Effect of transgenic overexpression of BMP antognist Noggin on skin tumour development; molecular mechanisms underlying tumour suppressive role of the BMP signalling in skin.
- Comprehensive analysis of the circular RNA expression profile and circRNA–miRNA–mRNA network in the goat skin with divergent wool curvature
- 329 Mechanisms of Cutaneous Adverse Events during Targeted Cancer Therapy